查看购物车
  • Traditional Chinese
  • English
  • Japanese
封面
市场调查报告书
商品编码
1797982

2032 年益智药市场预测：按产品类型、形式、分销管道、应用和地区进行的全球分析

Nootropics Market Forecasts to 2032 - Global Analysis By Product Type, Form, Distribution Channel, Application and By Geography
出版日期: | 出版商: Stratistics Market Research Consulting | 英文 200+ Pages | 商品交期: 2-3个工作天内

价格

根据 Stratistics MRC 的数据，全球益智药市场预计在 2025 年达到 57 亿美元，到 2032 年将达到 157 亿美元，预测期内的复合年增长率为 15.4%。

益智药，又称认知增强剂或智能药物，是旨在提高智力表现的天然或合成物质。这些化合物可以增强记忆力、注意力、创造力和警觉性等功能，且不会产生显着的副作用。益智药包括处方药、膳食补充剂和咖啡因等兴奋剂。其中一些已被临床核准用于治疗过动症和老年痴呆症疾病，而另一些则被列为仿单标示外，用于支持认知健康。

根据《食品科学与营养评论》发表的一篇系统性评价，分析了 2000 年至 2021 年间进行的 256 项人体研究，以评估植物来源益智药的认知效果。

社会越来越重视心理健康和认知能力

随着压力、倦怠和数位疲劳达到历史最高水平，消费者正在积极寻求能够增强注意力、记忆力和情绪韧性的补充剂。这种需求涵盖了广泛的人群，从学生、专业人士到老年人，他们都认为改善认知功能对于提高生产力和生活品质至关重要。健康文化的兴起，加上对健脑成分的科学检验日益增多，正在推动益智药作为日常自我护理的一部分被主流接受。

缺乏统一的法律规范

益智药通常处于膳食补充剂和药物之间的灰色地带，安全标准和标籤规范不一致。这种监管模糊性阻碍了产品审批，限制了国际贸易，并削弱了消费者信心。此外，在某些地区，未经证实的功效声明和不合格配方的盛行可能会引发卫生部门的检验，并减缓知名品牌的创新和市场准入。

电子商务和线上零售的兴起

线上平台为消费者提供丰富的产品选择、个人化建议以及有助于长期认知提升的订阅模式。网红行销、精准广告和教育内容正在提昇科技使用者的认知度和试用率。此外，直销品牌正在利用数据分析来改进配方，提高客户维繫。这种向数位优先商务的转变正在重塑分销策略，并使利基新兴企业能够实现全球覆盖。

负面宣传与消费者的强烈反对

益智药产业面临声誉风险，包括夸大宣传、滥用和缺乏透明度。媒体对益智药副作用和不道德销售行为的报告可能会引发消费者的质疑和监管机构的打击。此外，益智药与绩效压力和学术兴奋剂的关联可能会疏远注重健康的使用者。为了减轻负面影响，公司需要投资临床研究、透明的标籤和负责任的通讯，强调安全性、有效性和全人益处。

COVID-19的影响：

新冠疫情对益智药市场产生了双重影响，既扰乱了供应链，也刺激了需求。封锁和远距办公环境加剧了精神疲劳、焦虑和认知压力，促使消费者寻求增强大脑功能的补充剂。天然适应原和情绪调节化合物因其缓解压力的功效而广受欢迎。在生产方面，采购和製造延迟导致暂时短缺，尤其是进口草药成分的短缺。

天然益智药市场预计将在预测期内占据最大份额

由于消费者对洁净标示植物性认知增强剂的偏好日益增长，因此预计天然益智药领域将在预测期内占据最大的市场占有率。假马齿苋、红景天和猴头菇等成分因其适应原和神经保护特性而备受青睐。这些化合物满足了人们对永续、非合成健康解决方案日益增长的需求。萃取和生物利用度的技术进步正在提高功效，而阿育吠陀和中医等传统医学体系的融合则正在拓展产品的多样性。

预计在预测期内，记忆增强领域将以最高的复合年增长率成长。

受学术和专业表现日益增长的需求推动，记忆增强领域预计将在预测期内实现最高成长率。学生和职场人士正在转向使用益智药来增强回忆能力、提高学习速度和长期记忆。结合胞磷胆碱、丝胺酸和草药萃取物的配方因其协同效应而日益普及。此外，个人化组合和智慧交付系统的创新也使该领域受益，这些创新能够优化认知结果。

占比最大的地区：

预计北美将占据最大的市场占有率，在预测期内占总收益的40%以上。该地区浓厚的健康文化、高可支配收入和先进的医疗基础设施正在推动其普及。美国品牌在创新方面处于领先地位，提供素食、洁净标示和整合技术的个人化产品，以满足不同的认知需求。监管的明确性和消费者教育正在进一步推动市场成熟。

复合年增长率最高的地区：

预计北美将在预测期内实现最高的复合年增长率，这归因于快速数位化和不断变化的消费行为。电子商务、订阅模式和网红主导的宣传活动的兴起正在加速产品的普及。此外，该地区对预防性心理健康和个人化健康的关注正在推动配方和交付方面的创新。补充剂品牌与神经科学机构之间的策略合作伙伴关係进一步推动了成长，使北美成为认知增强技术的全球中心。

免费客製化服务：

此报告的订阅者可以使用以下免费自订选项之一：

  • 公司简介
    • 全面分析其他市场参与者（最多 3 家公司）
    • 主要企业的SWOT分析（最多3家公司）
  • 区域细分
    • 根据客户兴趣对主要国家进行的市场估计、预测和复合年增长率（註：基于可行性检查）
  • 竞争基准化分析
    • 根据产品系列、地理分布和策略联盟对主要企业基准化分析

目录

第一章执行摘要

第二章 前言

  • 概述
  • 相关利益者
  • 调查范围
  • 调查方法
    • 资料探勘
    • 数据分析
    • 数据检验
    • 研究途径
  • 研究材料
    • 主要研究资料
    • 二手研究资料
    • 先决条件

第三章市场走势分析

  • 驱动程式
  • 抑制因素
  • 机会
  • 威胁
  • 产品分析
  • 应用分析
  • 新兴市场
  • COVID-19的影响

第四章 波特五力分析

  • 供应商的议价能力
  • 买方的议价能力
  • 替代品的威胁
  • 新进入者的威胁
  • 竞争对手之间的竞争

5. 全球益智药市场（依产品类型）

  • 天然益智药
    • 草本萃取物
    • 胺基酸
    • Omega-3脂肪酸
  • 合成益智药
    • 拉西坦
    • 安帕基尼斯
    • 胆碱能促效剂
  • 处方笺药
    • Modafinil
    • 阿屈非尼
  • 其他产品类型

6. 全球益智药市场（依形式）

  • 胶囊/片剂
  • 粉末
  • 喝
  • 其他形式

7. 全球益智药市场（按分销管道）

  • 线上管道
  • 线下通路
    • 药局和药局
    • 超级市场和大卖场
    • 专卖店

8. 全球益智药市场（按应用）

  • 提升记忆力
  • 提高专注力和专注力
  • 情绪和压力管理
  • 抗衰老和神经保护
  • 疾病或受伤后的认知恢復
  • 其他用途

9. 全球益智药市场（按地区）

  • 北美洲
    • 美国
    • 加拿大
    • 墨西哥
  • 欧洲
    • 德国
    • 英国
    • 义大利
    • 法国
    • 西班牙
    • 其他欧洲国家
  • 亚太地区
    • 日本
    • 中国
    • 印度
    • 澳洲
    • 纽西兰
    • 韩国
    • 其他亚太地区
  • 南美洲
    • 阿根廷
    • 巴西
    • 智利
    • 南美洲其他地区
  • 中东和非洲
    • 沙乌地阿拉伯
    • 阿拉伯聯合大公国
    • 卡达
    • 南非
    • 其他中东和非洲地区

第十章：主要发展

  • 协议、伙伴关係、合作和合资企业
  • 收购与合併
  • 新产品发布
  • 业务扩展
  • 其他关键策略

第十一章 公司概况

  • Purelife Bioscience Co., Ltd.
  • TruBrain
  • HVMN Inc.
  • Peak Nootropics
  • SupNootropic Bio Co. Ltd.
  • AlternaScript HQ
  • Onnit Labs LLC
  • Accelerated Intelligence, Inc.
  • Merck & Co.
  • OptiMind
  • Clarity Nootropics
  • F. Hoffmann-La Roche Ltd.
  • Neurohacker Collective
  • AstraZeneca
  • Janssen Pharmaceuticals
  • Gaia Herbs, Inc.
  • Mind Lab Pro
Product Code: SMRC30352

According to Stratistics MRC, the Global Nootropics Market is accounted for $5.7 billion in 2025 and is expected to reach $15.7 billion by 2032 growing at a CAGR of 15.4% during the forecast period. Nootropics, is a cognitive enhancers or smart drugs, are natural or synthetic substances that aim to improve mental performance. These compounds may enhance functions such as memory, attention, creativity, and alertness without causing significant side effects. Nootropics include prescription medications, dietary supplements, and stimulants like caffeine. While some are clinically approved for conditions like ADHD or Alzheimer's, others are used off-label to support cognitive health, though scientific evidence for their effectiveness in healthy individuals remains limited

According to a systematic review published in Critical Reviews in Food Science and Nutrition, 256 human studies conducted between 2000 and 2021 were analyzed to assess the cognitive effects of plant-derived nootropics.

Market Dynamics:

Driver:

Increasing societal emphasis on mental well-being, cognitive performance

As stress, burnout, and digital fatigue become widespread, consumers are actively seeking supplements that enhance focus, memory, and emotional resilience. This demand spans across demographics from students and professionals to aging populations who view cognitive enhancement as essential to productivity and quality of life. The rise of wellness culture, coupled with increased scientific validation of brain-boosting ingredients, is fostering mainstream acceptance of nootropics as part of daily self-care routines.

Restraint:

Lack of uniform regulatory oversight

Nootropics often fall into a gray area between dietary supplements and pharmaceuticals, leading to inconsistent safety standards and labeling practices. This regulatory ambiguity can hinder product approvals, limit international trade, and erode consumer trust. Moreover, the proliferation of unverified claims and substandard formulations in some regions has prompted scrutiny from health authorities, potentially slowing innovation and market entry for reputable brands.

Opportunity:

Expansion of E-commerce and online retail

Online platforms offer consumers access to a wide array of products, personalized recommendations, and subscription-based models that support long-term cognitive enhancement. Influencer marketing, targeted ads, and educational content are driving awareness and trial among tech-savvy users. Additionally, direct-to-consumer brands are leveraging data analytics to refine formulations and improve customer retention. This shift toward digital-first commerce is reshaping distribution strategies and enabling global reach for niche and emerging players.

Threat:

Negative publicity and consumer backlash

The nootropics industry faces reputational risks stemming from exaggerated claims, misuse, and lack of transparency. Media coverage of adverse effects or unethical marketing practices can trigger consumer skepticism and regulatory crackdowns. Furthermore, the association of nootropics with performance pressure or academic doping may alienate wellness-focused users. To mitigate backlash, companies must invest in clinical research, transparent labeling, and responsible messaging that emphasizes safety, efficacy, and holistic benefits.

Covid-19 Impact:

The COVID-19 pandemic had a dual impact on the nootropics market, disrupting supply chains while simultaneously amplifying demand. Lockdowns and remote work environments intensified mental fatigue, anxiety, and cognitive strain, prompting consumers to explore brain-enhancing supplements. Natural adaptogens and mood-regulating compounds gained popularity for their stress-relief properties. On the production side, delays in sourcing and manufacturing led to temporary shortages, especially for imported herbal ingredients.

The natural nootropics segment is expected to be the largest during the forecast period

The natural nootropics segment is expected to account for the largest market share during the forecast period driven by rising consumer preference for clean-label, plant-based cognitive enhancers. Ingredients such as Bacopa monnieri, Rhodiola rosea, and Lion's Mane mushroom are favored for their adaptogenic and neuroprotective properties. These compounds align with the growing demand for sustainable, non-synthetic wellness solutions. Technological advancements in extraction and bioavailability are improving efficacy, while the integration of traditional medicine systems like Ayurveda and TCM is expanding product diversity.

The memory enhancement segment is expected to have the highest CAGR during the forecast period

Over the forecast period, the memory enhancement segment is predicted to witness the highest growth rate fueled by increasing academic and professional performance demands. Students and working professionals are turning to nootropics that support recall, learning speed, and long-term retention. Formulations combining citicoline, phosphatidylserine, and herbal extracts are gaining popularity for their synergistic effects. The segment is also benefiting from innovations in personalized stacks and smart delivery systems that optimize cognitive outcomes.

Region with largest share:

During the forecast period, the North America region is expected to hold the largest market share accounting for over 40% of total revenue. The region's strong wellness culture, high disposable income, and advanced healthcare infrastructure support widespread adoption. U.S.-based brands lead in innovation, offering vegan, clean-label, and tech-integrated products tailored to diverse cognitive needs. Regulatory clarity and consumer education further enhance market maturity.

Region with highest CAGR:

Over the forecast period, the North America region is anticipated to exhibit the highest CAGR attributed to rapid digital adoption and evolving consumer behavior. The proliferation of e-commerce, subscription models, and influencer-led campaigns is accelerating product uptake. Moreover, the region's emphasis on preventive mental health and personalized wellness is fostering innovation in formulation and delivery. Strategic partnerships between supplement brands and neuroscience labs are further propelling growth, positioning North America as a global hub for cognitive enhancement technologies

Key players in the market

Some of the key players in Nootropics Market include Purelife Bioscience Co., Ltd., TruBrain, HVMN Inc., Peak Nootropics, SupNootropic Bio Co. Ltd., AlternaScript HQ, Onnit Labs LLC, Accelerated Intelligence, Inc., Merck & Co., OptiMind, Clarity Nootropics, F. Hoffmann-La Roche Ltd., Neurohacker Collective, AstraZeneca, Janssen Pharmaceuticals, Gaia Herbs, Inc. and Mind Lab Pro.

Key Developments:

In June 2025, Accelerated Intelligence, Inc. Company launched new digital content and coaching tools focused on emotional intelligence and cognitive performance. Excelerol remains its flagship supplement.

In June 2025, AstraZeneca announced a major expansion of its Global Hub in Bangalore, adding 400 jobs and boosting AI-driven R&D. The move supports its goal of delivering 20 new medicines by 2030.

In March 2025, OptiMind entered a letter of intent to acquire Monjin, an AI-powered recruitment platform. The deal includes equity restructuring and a name change to reflect expanded business focus.

Product Types Covered:

  • Natural Nootropics
  • Synthetic Nootropics
  • Prescription Nootropics
  • Other Product Types

Forms Covered:

  • Capsules/Tablets
  • Powders
  • Drinks/Beverages
  • Other Forms

Distribution Channels Covered:

  • Online Channels
  • Offline Channels

Applications Covered:

  • Memory Enhancement
  • Attention & Focus Improvement
  • Mood & Stress Management
  • Anti-Aging & Neuroprotection
  • Cognitive Recovery after Illness or Injury
  • Other Applications

Regions Covered:

  • North America
    • US
    • Canada
    • Mexico
  • Europe
    • Germany
    • UK
    • Italy
    • France
    • Spain
    • Rest of Europe
  • Asia Pacific
    • Japan
    • China
    • India
    • Australia
    • New Zealand
    • South Korea
    • Rest of Asia Pacific
  • South America
    • Argentina
    • Brazil
    • Chile
    • Rest of South America
  • Middle East & Africa
    • Saudi Arabia
    • UAE
    • Qatar
    • South Africa
    • Rest of Middle East & Africa

What our report offers:

  • Market share assessments for the regional and country-level segments
  • Strategic recommendations for the new entrants
  • Covers Market data for the years 2024, 2025, 2026, 2028, and 2032
  • Market Trends (Drivers, Constraints, Opportunities, Threats, Challenges, Investment Opportunities, and recommendations)
  • Strategic recommendations in key business segments based on the market estimations
  • Competitive landscaping mapping the key common trends
  • Company profiling with detailed strategies, financials, and recent developments
  • Supply chain trends mapping the latest technological advancements

Free Customization Offerings:

All the customers of this report will be entitled to receive one of the following free customization options:

  • Company Profiling
    • Comprehensive profiling of additional market players (up to 3)
    • SWOT Analysis of key players (up to 3)
  • Regional Segmentation
    • Market estimations, Forecasts and CAGR of any prominent country as per the client's interest (Note: Depends on feasibility check)
  • Competitive Benchmarking
    • Benchmarking of key players based on product portfolio, geographical presence, and strategic alliances

Table of Contents

1 Executive Summary

2 Preface

  • 2.1 Abstract
  • 2.2 Stake Holders
  • 2.3 Research Scope
  • 2.4 Research Methodology
    • 2.4.1 Data Mining
    • 2.4.2 Data Analysis
    • 2.4.3 Data Validation
    • 2.4.4 Research Approach
  • 2.5 Research Sources
    • 2.5.1 Primary Research Sources
    • 2.5.2 Secondary Research Sources
    • 2.5.3 Assumptions

3 Market Trend Analysis

  • 3.1 Introduction
  • 3.2 Drivers
  • 3.3 Restraints
  • 3.4 Opportunities
  • 3.5 Threats
  • 3.6 Product Analysis
  • 3.7 Application Analysis
  • 3.8 Emerging Markets
  • 3.9 Impact of Covid-19

4 Porters Five Force Analysis

  • 4.1 Bargaining power of suppliers
  • 4.2 Bargaining power of buyers
  • 4.3 Threat of substitutes
  • 4.4 Threat of new entrants
  • 4.5 Competitive rivalry

5 Global Nootropics Market, By Product Type

  • 5.1 Introduction
  • 5.2 Natural Nootropics
    • 5.2.1 Herbal Extracts
    • 5.2.2 Amino Acids
    • 5.2.3 Omega-3 Fatty Acids
  • 5.3 Synthetic Nootropics
    • 5.3.1 Racetams
    • 5.3.2 Ampakines
    • 5.3.3 Cholinergics
  • 5.4 Prescription Nootropics
    • 5.4.1 Modafinil
    • 5.4.2 Adrafinil
  • 5.5 Other Product Types

6 Global Nootropics Market, By Form

  • 6.1 Introduction
  • 6.2 Capsules/Tablets
  • 6.3 Powders
  • 6.4 Drinks/Beverages
  • 6.5 Other Forms

7 Global Nootropics Market, By Distribution Channel

  • 7.1 Introduction
  • 7.2 Online Channels
  • 7.3 Offline Channels
    • 7.3.1 Pharmacies & Drugstores
    • 7.3.2 Supermarkets & Hypermarkets
    • 7.3.3 Specialty Stores

8 Global Nootropics Market, By Application

  • 8.1 Introduction
  • 8.2 Memory Enhancement
  • 8.3 Attention & Focus Improvement
  • 8.4 Mood & Stress Management
  • 8.5 Anti-Aging & Neuroprotection
  • 8.6 Cognitive Recovery after Illness or Injury
  • 8.7 Other Applications

9 Global Nootropics Market, By Geography

  • 9.1 Introduction
  • 9.2 North America
    • 9.2.1 US
    • 9.2.2 Canada
    • 9.2.3 Mexico
  • 9.3 Europe
    • 9.3.1 Germany
    • 9.3.2 UK
    • 9.3.3 Italy
    • 9.3.4 France
    • 9.3.5 Spain
    • 9.3.6 Rest of Europe
  • 9.4 Asia Pacific
    • 9.4.1 Japan
    • 9.4.2 China
    • 9.4.3 India
    • 9.4.4 Australia
    • 9.4.5 New Zealand
    • 9.4.6 South Korea
    • 9.4.7 Rest of Asia Pacific
  • 9.5 South America
    • 9.5.1 Argentina
    • 9.5.2 Brazil
    • 9.5.3 Chile
    • 9.5.4 Rest of South America
  • 9.6 Middle East & Africa
    • 9.6.1 Saudi Arabia
    • 9.6.2 UAE
    • 9.6.3 Qatar
    • 9.6.4 South Africa
    • 9.6.5 Rest of Middle East & Africa

10 Key Developments

  • 10.1 Agreements, Partnerships, Collaborations and Joint Ventures
  • 10.2 Acquisitions & Mergers
  • 10.3 New Product Launch
  • 10.4 Expansions
  • 10.5 Other Key Strategies

11 Company Profiling

  • 11.1 Purelife Bioscience Co., Ltd.
  • 11.2 TruBrain
  • 11.3 HVMN Inc.
  • 11.4 Peak Nootropics
  • 11.5 SupNootropic Bio Co. Ltd.
  • 11.6 AlternaScript HQ
  • 11.7 Onnit Labs LLC
  • 11.8 Accelerated Intelligence, Inc.
  • 11.9 Merck & Co.
  • 11.10 OptiMind
  • 11.11 Clarity Nootropics
  • 11.12 F. Hoffmann-La Roche Ltd.
  • 11.13 Neurohacker Collective
  • 11.14 AstraZeneca
  • 11.15 Janssen Pharmaceuticals
  • 11.16 Gaia Herbs, Inc.
  • 11.17 Mind Lab Pro

List of Tables

  • Table 1 Global Nootropics Market Outlook, By Region (2024-2032) ($MN)
  • Table 2 Global Nootropics Market Outlook, By Product Type (2024-2032) ($MN)
  • Table 3 Global Nootropics Market Outlook, By Natural Nootropics (2024-2032) ($MN)
  • Table 4 Global Nootropics Market Outlook, By Herbal Extracts (2024-2032) ($MN)
  • Table 5 Global Nootropics Market Outlook, By Amino Acids (2024-2032) ($MN)
  • Table 6 Global Nootropics Market Outlook, By Omega-3 Fatty Acids (2024-2032) ($MN)
  • Table 7 Global Nootropics Market Outlook, By Synthetic Nootropics (2024-2032) ($MN)
  • Table 8 Global Nootropics Market Outlook, By Racetams (2024-2032) ($MN)
  • Table 9 Global Nootropics Market Outlook, By Ampakines (2024-2032) ($MN)
  • Table 10 Global Nootropics Market Outlook, By Cholinergics (2024-2032) ($MN)
  • Table 11 Global Nootropics Market Outlook, By Prescription Nootropics (2024-2032) ($MN)
  • Table 12 Global Nootropics Market Outlook, By Modafinil (2024-2032) ($MN)
  • Table 13 Global Nootropics Market Outlook, By Adrafinil (2024-2032) ($MN)
  • Table 14 Global Nootropics Market Outlook, By Other Product Types (2024-2032) ($MN)
  • Table 15 Global Nootropics Market Outlook, By Form (2024-2032) ($MN)
  • Table 16 Global Nootropics Market Outlook, By Capsules/Tablets (2024-2032) ($MN)
  • Table 17 Global Nootropics Market Outlook, By Powders (2024-2032) ($MN)
  • Table 18 Global Nootropics Market Outlook, By Drinks/Beverages (2024-2032) ($MN)
  • Table 19 Global Nootropics Market Outlook, By Other Forms (2024-2032) ($MN)
  • Table 20 Global Nootropics Market Outlook, By Distribution Channel (2024-2032) ($MN)
  • Table 21 Global Nootropics Market Outlook, By Online Channels (2024-2032) ($MN)
  • Table 22 Global Nootropics Market Outlook, By Offline Channels (2024-2032) ($MN)
  • Table 23 Global Nootropics Market Outlook, By Pharmacies & Drugstores (2024-2032) ($MN)
  • Table 24 Global Nootropics Market Outlook, By Supermarkets & Hypermarkets (2024-2032) ($MN)
  • Table 25 Global Nootropics Market Outlook, By Specialty Stores (2024-2032) ($MN)
  • Table 26 Global Nootropics Market Outlook, By Application (2024-2032) ($MN)
  • Table 27 Global Nootropics Market Outlook, By Memory Enhancement (2024-2032) ($MN)
  • Table 28 Global Nootropics Market Outlook, By Attention & Focus Improvement (2024-2032) ($MN)
  • Table 29 Global Nootropics Market Outlook, By Mood & Stress Management (2024-2032) ($MN)
  • Table 30 Global Nootropics Market Outlook, By Anti-Aging & Neuroprotection (2024-2032) ($MN)
  • Table 31 Global Nootropics Market Outlook, By Cognitive Recovery after Illness or Injury (2024-2032) ($MN)
  • Table 32 Global Nootropics Market Outlook, By Other Applications (2024-2032) ($MN)

Note: Tables for North America, Europe, APAC, South America, and Middle East & Africa Regions are also represented in the same manner as above.